Back to top

Tale of the Tape

ChemoCentryx Inc. ’s (CCXI - Snapshot Report) share price has entered into oversold territory with an RSI value of 28.52. The Zacks Consensus Estimate on CCXI’s loss for the full year period has moved lower by 12 cents over the past two months to $1.03 per share. Currently, ChemoCentryx Inc. is a Zacks #2 Rank (“Buy”), suggesting that now might be a good time to get in on (CCXI - Snapshot Report) after its recent drop.